An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma
- 21 March 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 25 (2), 309-317
- https://doi.org/10.1016/s0731-7085(00)00506-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Simultaneous Determination of Unlabeled and Deuterium-Labeled Indinavir in Human Plasma by High-Performance Liquid Chromatography with Tandem Mass Spectrometric DetectionJournal of Pharmaceutical Sciences, 1997
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- Nosocomial outbreak of tuberculosis in an outpatient HIV treatment roomAIDS, 1996
- Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switchingJournal of Chromatography A, 1995
- Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524Tetrahedron Letters, 1994
- L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease InhibitorJournal of Medicinal Chemistry, 1994
- High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samplesAnalytical Chemistry, 1986